Status:
COMPLETED
Stress, Diurnal Cortisol, and Breast Cancer Survival
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Breast Cancer
Eligibility:
FEMALE
35+ years
Brief Summary
The purpose of this study is to learn about the effects of stress on hormones, the relationship between these hormones and cancer progression.
Detailed Description
The purpose of this study is to investigate stress and tonic activation of diurnal cortisol in aging metastatic breast cancer patients; feedback inhibition \& activation of cortisol; and stress-induce...
Eligibility Criteria
Inclusion
- Diagnosis of recurrent or metastatic breast cancer.
- Karnofsky of 70% or greater.
- Proficient enough in English to be able to take questionnaires and participate in the required tasks.
- Living within the Greater Bay Area.
- Age 35 or older .
Exclusion
- Positive supraclavicular lymph nodes as the only metastatic lesion at the time of initial diagnosis.
- Active cancers within the past 10 years other than breast cancer, basal cell or squamous cell carcinomas of the skin, or in situ cancer of the cervix.
- Any other serious medical condition that will effect short term survival
- History of major psychiatric illness for which patient was hospitalized or medicated, with the exception of depression or anxiety
- A diagnosis of diabetes.
Key Trial Info
Start Date :
September 8 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2005
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT00226967
Start Date
September 8 2002
End Date
December 1 2005
Last Update
January 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305